Instruction for use: Inflexal V

Dosage form: Suspension for intramuscular and subcutaneous administration

Active substance: Vaccinum ad prophylaxim grippi inactivatum

ATX

J07BB01 Influenza virus inactivated whole

Pharmacological group

Vaccines, serums, phages and toxoids

The nosological classification (ICD-10)

J11 Influenza, virus not identified: Influenza; Influenza in the early stages of the disease; Influenza in children; cold in the chest; Begins flu-like condition; Acute disease parainfluenza; parainfluenza; parainfluenza state; influenza epidemics; The pains of the influenza

Composition

Suspension for intramuscular and subcutaneous administration 1 dose (0.5 ml)

Active substances: Hemagglutinin of the influenza virus *:

A (H1N1) -like 15 μg

A (H3N2) -like 15 μg

B-like 15 mcg

Auxiliary substances: sodium chloride - 2.4 mg; Sodium hydrogen phosphate dihydrate - 3.8 mg; Potassium dihydrogen phosphate 0.7 mg; Lecithin - 117 mcg; Water for injection - up to 0.5 ml

* Indicated in accordance with the WHO recommendations for this epidemic season

Pharmachologic effect

Mode of action - Immunostimulating.

Dosing and Administration

IM, SC deep.

Adults and children older than 36 months: 0.5 ml.

Children aged 6 to 35 months: 0.25 or 0.5 ml.

Children who have not previously been vaccinated should re-enter the appropriate dose of the vaccine at intervals of not less than 4 weeks.

Allow the vaccine to warm to room temperature before use. Shake well before administration.

If a dose of 0.25 ml is prescribed, half the volume of the vaccine is removed from the syringe to the risks by holding the syringe in an upright position. The remaining volume is entered.

Release form

Suspension for intramuscular and subcutaneous administration. For 0.5 ml in a disposable sterile glass syringe with a needle. 1 syringe in a plastic blister. For 1 or 10 blisters in a cardboard bundle.

Manufacturer

Crusell Switzerland AG, Rehhagstrasse 79, 3018 Bern, Switzerland.

About cases of post-vaccination complications after the Inflexal® V vaccine should be reported to the National Control Authority of the IIBP - FGBU "GISK im. L.À.Tarasevich »of the Ministry of Health and Social Development of the Russian Federation 

Conditions of supply of pharmacies

On prescription.

Storage conditions of the drug Inflexal V

At a temperature of 2-8 ° C (do not freeze).

Keep out of the reach of children.

The shelf life of the drug Inflexal V

1 year.

Do not use beyond the expiration date printed on the package.